|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.088 EUR | +0.60% |
|
+0.33% | -15.07% |
| 05:25pm | Grifols Launches Fesilty in the U.S | CI |
| 04:45pm | Grifols Launches Fesilty Blood Clotting Concentrate in US | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 6.4B | |||||
| 62.28B | |||||
| 60.59B | |||||
| 39.55B | |||||
| 36.8B | - | ||||
| 29.53B |
- Stock Market
- Stocks
- GRF Stock
- Charts Grifols, S.A.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition